• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

ALCLS:FP

12.9500 EUR 0.3700 2.94%

As of 03:55:29 ET on 07/30/2014.

Snapshot for Cellectis (ALCLS)

Open: 12.7000 Day's Range: 12.6500 - 12.9600 Volume: 27,855
Previous Close: 12.5800 52wk Range: 2.1100 - 14.5800 1-Yr Rtn: +185.87%

Stock Chart for ALCLS

No chart data available.
  • ALCLS:FP 12.9400
  • 1D
  • 1M
  • 1Y
12.5800
Interactive ALCLS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALCLS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -2.9600
Est. EPS (EUR) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 315.54
Shares Outstanding (M) 25.08
30 Day Average Volume 441,109
Price/Book (mrq) 4.0017
Price/Sale (ttm) 16.3249
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALCLS

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ALCLS

Cellectis produces proteins for therapeutic purposes, researches improvements in seed characteristics, and develops treatments against single-gene disorders and against infections by DNA viruses.

Andre ChoulikaChairman/CEO/Co-FounderThierry MoulinChief Financial Officer
Mathieu SimonExec Vice PresidentPhilippe ValachsSecretary
More Company Profile & Key Executives for ALCLS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil